Heart Test Laboratories, Inc. (HSCS)

USD 3.76

(-2.21%)

Market Cap (In USD)

3.43 Million

Revenue (In USD)

18.6 Thousand

Net Income (In USD)

-6.6 Million

Avg. Volume

384.87 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.36-18.5
PE
-
EPS
-
Beta Value
3.294
ISIN
US42254E1047
CUSIP
42254E104
CIK
1468492
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Andrew Simpson
Employee Count
-
Website
https://heartsciences.com
Ipo Date
2022-06-16
Details
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.